Trials Avoid High Risk Patients and Underestimate Drug Harms
收藏NBER2025-12-01 更新2025-12-13 收录
下载链接：
https://www.nber.org/papers/w34534
下载链接
链接失效反馈官方服务：
资源简介：
The FDA does not formally regulate representativeness, but if trials under-enroll vulnerable patients, the resulting evidence may understate harm from drugs. We study the relationship between trial participation and the risk of drug-induced adverse events for cancer medications using data from the
提供机构：
美国国家经济研究局
创建时间：
2025-12-01
